A report by the National Academy of Sciences, Engineering, and Medicine recommends that HHS and other federal agencies form an independent organization that would rely on complex adaptive sysytems to direct cancer control in the U.S.
The Oncologic Drugs Advisory Committee held its first session since President Trump’s inauguration, with a two-day, back-to-back marathon meeting, signaling a return to business at FDA after significant upheaval at the agency.
